# An Add-on Study to Evaluate the Efficacy and Safety of Xiyanping Injection in Pediatric Bronchitis Patients.

> **NCT02937857** · PHASE4 · UNKNOWN · sponsor: **Jiangxi Qingfeng Pharmaceutical Co. Ltd.** · enrollment: 240 (estimated)

## Conditions studied

- Bronchitis

## Interventions

- **DRUG:** Standard treatment only
- **DRUG:** Standard treatment+Xiyanping injection

## Key facts

- **NCT ID:** NCT02937857
- **Lead sponsor:** Jiangxi Qingfeng Pharmaceutical Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08
- **Primary completion:** 2020-04
- **Final completion:** 2020-08
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2017-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02937857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02937857, "An Add-on Study to Evaluate the Efficacy and Safety of Xiyanping Injection in Pediatric Bronchitis Patients.". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT02937857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*